Xiaofei Li
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Geriatrics and Gerontology top 5%
Papers in
-
- Cancer, Hypoxia, and Metabolism 11
-
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 12
- Tracheal and airway disorders 11
Xiaofei Li
112 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 753
- Geriatrics and Gerontology 123
- Molecular Biology 1.5k
- Pulmonary and Respiratory Medicine 684
- Oncology 457
Countries citing papers authored by Xiaofei Li
This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).
Fields of papers citing papers by Xiaofei Li
This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaofei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 40 | |
| 10 | 2021 | 2 | |
| 11 | 2018 | 8 | |
| 12 | 2016 | 52 | |
| 13 | 2016 | 1 | |
| 14 | 2016 | 37 | |
| 15 | 2015 | 10 | |
| 16 | 2013 | 4 | |
| 17 | 2012 | 14 | |
| 18 | 2011 | 12 | |
| 19 | Impact of STYK1/NOK gene transfection on the migration and invasion of lung adenocarcinoma cell line | 2011 | 1 |
| 20 | 2009 | 30 |
About Xiaofei Li
Xiaofei Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Speech and Hearing, having authored 122 papers that have together received 2.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (12 papers), Tracheal and airway disorders (11 papers), Cancer, Hypoxia, and Metabolism (11 papers), RNA modifications and cancer (10 papers), Epigenetics and DNA Methylation (8 papers), Esophageal and GI Pathology (8 papers) and Cancer Cells and Metastasis (6 papers). The work is most often cited by research in Cancer Research (753 citations), Geriatrics and Gerontology (123 citations), Molecular Biology (1.5k citations), Pulmonary and Respiratory Medicine (684 citations) and Oncology (457 citations). Xiaofei Li has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Yong Han, Xiaolong Yan, Yanlu Xiong, Lintao Jia, Yangbo Feng, Tianyun Qiao, Zhipei Zhang, Lijun Huang, Zhiqiang Ma and Jinbo Zhao. Their work appears in journals such as Scientific Reports, Journal of Thoracic and Cardiovascular Surgery, Diagnostic Pathology, Journal of Cancer Research and Clinical Oncology and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.